; and (2) the needs of the States, as determined based on the populations of each State. (c) Funding Amounts available in the Defense Production Act Fund under section 304 of the Defense Production Act of 1950 ( 50 U.S.C. 4534 ) shall be available to carry out this section. (d) Termination (1) In general This section shall terminate on the date on which there are no remaining requests under subsection (b)(1). (2) Disposition of unused supplies necessary for equitably distributing or administering the COVID–19 vaccine Any supplies produced pursuant to subsection (a)(3)(A) using amounts from the Defense Production Act Fund and unused as of the date described in paragraph (1) shall be deposited in the Strategic National Stockpile under section 319F–2 of the Public Health Service Act ( 42 U.S.C. 247d–6b ), including any such supplies authorized for emergency use under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ). (e) Definitions In this section: (1) COVID–19 vaccine The term COVID–19 vaccine means a vaccine to prevent or mitigate COVID–19 that the Food and Drug Administration licenses or authorizes for emergency use. (2) State The term State includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, American Samoa, and the Commonwealth of the Northern Mariana Islands.